- Home
- ZJYL vs FGEN Comparison
ZJYL vs FGEN Comparison
Compare ZJYL & FGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZJYL | FGEN |
|---|---|---|
| Founded | 2006 | 1993 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.5M | 35.6M |
| IPO Year | 2023 | 2014 |
Fundamental Metrics
Financial Performance| Metric | ZJYL | FGEN |
|---|---|---|
| Price | $0.24 | $8.12 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $146.50 |
| AVG Volume (30 Days) | ★ 1.7M | 40.1K |
| Earning Date | 08-20-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.01 | ★ 53.38 |
| Revenue | ★ $22,826,624.00 | $8,298,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $21.46 | ★ $0.15 |
| Revenue Growth | ★ 13.42 | N/A |
| 52 Week Low | $0.22 | $4.85 |
| 52 Week High | $1.42 | $21.94 |
Technical Indicators
Market Signals| Indicator | ZJYL | FGEN |
|---|---|---|
| Relative Strength Index (RSI) | 31.88 | 28.08 |
| Support Level | $0.24 | $8.06 |
| Resistance Level | $0.28 | $9.11 |
| Average True Range (ATR) | 0.02 | 0.40 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 9.83 | 4.44 |
Price Performance
Historical ComparisonAbout ZJYL JIN MEDICAL INTERNATIONAL LTD.
Jin Medical International Ltd offers rehabilitation equipment. It is engaged in the design, development, manufacturing, and sales of wheelchairs and other living aids products to be used by people with disabilities or impaired mobility. The company's products are sold to distributors in both China and overseas markets. Its product offerings comprise Wheelechaire serirs, Bath products, oxygen machines, and nursing products. Geographically, it generates the majority of its revenue from Japan.
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.